Enzyme Price

Enzyme is a decentralized finance (DeFi) protocol and cryptocurrency that enables on-chain asset management in the Ethereum ecosystem. It allows users to create, share, and explore investment strategies called 'vaults' that can be filtered based on historical performance and risk profiles. The MLN token is used to pay for various functions throughout the vault creation process and investment lifecycle. Key features of Enzyme: 1. Decentralized asset management platform 2. Enables creation of customizable investment vaults 3. Facilitates exploration of DeFi investment strategies 4. Utilizes MLN tokens for ecosystem operations MLN has a current price of $3.12 with a 24-hour trading volume of $404.25. The total supply is 3.27M MLN MLN, and the circulating supply is 3.27M MLN. Enzyme's market cap stands at $10.24M, ranking it #1079 among all cryptocurrencies. Looking ahead, some price predictions for Enzyme include: - 2027: $3.75 - 2031: $5.57 - 2036: -- As a utility token, MLN plays a crucial role in powering the Enzyme ecosystem and aligning stakeholder interests.

Enzyme was created on February 1, 2017. It was launched as an Ethereum-based token to support the Enzyme protocol (formerly known as Melon protocol), which aims to facilitate on-chain asset management in the DeFi ecosystem. The project's goal is to enable users to build, share, and explore DeFi investment strategies through 'vaults' that can be filtered based on historical performance and risk profiles. Since its inception, Enzyme has played a crucial role in powering the ecosystem and aligning stakeholders' interests.

The founders of Enzyme (MLN) are Mona El Isa and Reto Trinkler. They co-founded the project in 2016, originally under the name Melon Protocol, which later rebranded to Enzyme Finance. Mona El Isa, a former Goldman Sachs trader, serves as the CEO of Avantgarde Finance, the company developing Enzyme. Reto Trinkler, a blockchain developer and entrepreneur, was instrumental in the initial development of the protocol. Together, they aimed to create a decentralized asset management infrastructure on the Ethereum blockchain, enabling users to build, manage, and invest in on-chain investment vehicles called 'vaults'. Their vision has helped shape Enzyme into a leading platform for decentralized asset management in the DeFi ecosystem.

Enzyme works as a utility token powering the Enzyme protocol, which enables on-chain asset management in the DeFi ecosystem. Users can create, share, and explore investment strategies called 'vaults' using MLN. The token is used to pay for various functions throughout the vault creation process and investment lifecycle. MLN has two main purposes: 1. Users pay fees in MLN for using the protocol's services. 2. Developers and contributors can earn MLN by submitting grants and improvements. The protocol allows users to build customized investment strategies, filter vaults based on historical performance and risk profiles, and participate in decentralized asset management. As of 2026-04-29, Enzyme has a market cap of $10.24M and is trading at $3.12. The circulating supply is 3.27M MLN MLN, with a total supply capped at 3.27M MLN MLN.

Enzyme utilizes a modular architecture built on Ethereum. Its core components include: 1. Smart contracts: These handle vault creation, asset management, and protocol governance. 2. Enzyme Protocol: The main protocol layer that coordinates interactions between different modules. 3. Vault system: Allows users to create and manage on-chain investment portfolios. 4. Integration layer: Connects Enzyme to various DeFi protocols and liquidity sources. 5. Risk management tools: Provide analytics and risk assessment for vaults. 6. Governance module: Enables MLN token holders to participate in protocol decisions. 7. Asset universe: A curated list of supported assets and protocols for investment. This architecture enables Enzyme to offer decentralized asset management capabilities while maintaining flexibility and upgradability. The modular design allows for easy integration of new features and DeFi protocols as the ecosystem evolves.

The future and roadmap of Enzyme (MLN) look promising. The project aims to continue enhancing its on-chain asset management capabilities within the DeFi ecosystem. Key focus areas include: 1. Expanding supported assets and protocols to offer more diverse investment strategies. 2. Improving user experience and accessibility to attract more users to create and explore DeFi vaults. 3. Developing advanced risk management and analytics tools for better portfolio optimization. 4. Fostering partnerships with other DeFi projects to increase integration and utility of MLN tokens. 5. Implementing governance upgrades to further decentralize decision-making. 6. Scaling infrastructure to handle increased adoption and transaction volumes. By 2027, Enzyme aims to be among the top 500 cryptocurrencies by market cap. The team projects a potential price of $3.75 by then. Long-term price predictions suggest MLN could reach $5.57 by 2031 and -- by 2036, though these are speculative estimates. Overall, Enzyme's roadmap focuses on solidifying its position as a leading DeFi asset management protocol while driving adoption and token value growth.